Brief answers from human studies
Retatrutide questions with plain study answers
Eli Lilly tested retatrutide in Phase 1b, an early safety study, and Phase 2. The findings answer some questions, but they don't provide dose advice.
The half-life of retatrutide is close to a week
Eli Lilly first tested retatrutide in people with type 2 diabetes [4]. Phase 1b was a study of safety and time in blood.
The study found a half-life near 6 days. Your blood held half as much drug after that time.
Retatrutide half life explains the finding. It can't tell you how long benefit or harm would last in your body or what you would feel.
Retatrutide leaves the blood slowly over time
Phase 1b, an early blood test, found a half-life near 6 days [4]. Your blood level dropped by half about every 6 days.
The drug stayed high enough to measure for roughly 3–4 weeks. That doesn't mean a benefit lasted for all that time.
Very little drug remained by then. That still doesn't tell you when harm ended.
With weekly study shots, blood levels evened out after 4–5 weeks. This finding can't set a dose for you.
What does retatrutide do in the body?
Retatrutide acts like three hormones. GLP-1 can ease your hunger. GIP tells your pancreas to send insulin when you eat.
The third is glucagon. Between meals, it may push blood sugar higher and help burn your stored fat.
In Phase 2, weight fell up to 24.2% by week 48 [1]. A 2025 review called that larger than earlier results [6].
The group finding can't foretell your response. It doesn't show whether your benefit would outweigh your harm.
How does retatrutide work through three hormones?
The drug is a 39-amino-acid chain, built from small protein pieces. A fat part helps it remain in blood near 6 days [4].
GLP-1 can ease hunger. GIP helps with insulin after meals. Glucagon can make your body burn stored fat.
A lab study showed cells could react to all three hormone effects [3]. Work in cells can't show how your whole body would respond.
How does retatrutide work gives the full account. The page won't give use directions.
How to reconstitute retatrutide has no safe answer
There isn't an approved retatrutide product to mix. Study staff used drug made for the trials.
Online powder has no sure identity, strength, or cleanliness. You can't fix those gaps with a mixing recipe.
This site gives no such directions. An unknown shot can cause grave harm.
No recipe can settle what is inside a vial. You can't protect your health by mixing an unknown powder more carefully.
Is retatrutide FDA approved: no
No. Retatrutide remains investigational, without FDA approval.
The drug remained in Phase 3 studies. One Phase 3 study includes people with type 2 diabetes.
Two large tests were still under way. A separate heart study was also running.
Authorized clinical trials can provide investigational retatrutide under study controls. Before FDA approval, no doctor may write you a prescription.
When will retatrutide be available: no date is known
No date has been announced because Phase 3 studies must finish first. Phase 3 is the last large test before FDA review.
Then Eli Lilly must send the FDA a full request for approval. The FDA may approve or reject the drug.
Review often takes 1–2 years after that request arrives. No one can promise the same timing here.
A guessed date may sound useful while you wait. It can't give your doctor a lawful medicine sooner.
Retatrutide medicine access is limited to trials
Retatrutide is an investigational study drug, with no lawful telehealth prescribing route. Some open studies appear on ClinicalTrials.gov.
Outside a study, the drug has no approved use. A doctor can't write you a lawful prescription.
Online vials aren't approved or checked. Their labels may not tell the truth.
Study staff can tell you whether you may join. An online seller can't give your health the same checks.
How to take retatrutide has no approved answer
Study teams put the needle into fatty tissue. They gave the shot once a week.
No study has published a pill or other form. The drug has no approved use directions.
This page tells you what researchers did. It doesn't tell you how to treat yourself.
The study route belongs to the study itself. It isn't a set of steps for you or a reason to risk your health.
How long retatrutide takes to work isn't known for you
Phase 2 found weight loss in the first weeks [1]. At week 48, weight was still dropping.
The drug reached even blood levels after about 4–5 weeks, and its half-life sets the timing. The study calls this a 6-day half-life.
A 2025 review called the early and lasting change unusual [6]. You can't use averages to predict your result.
Early group changes can give you a sense of timing. They can't name the week when you or your body would change.
Retatrutide isn't yet proven better than tirzepatide
No fair side-by-side result is public yet. A Phase 3 study is now comparing the drugs [11].
One Phase 2 study tested retatrutide. A different Phase 2 study tested tirzepatide.
Retatrutide reached 24.2% at 12 mg over 48 weeks. The groups and study lengths weren't alike.
You can't name a winner from two unlike studies.
How much retatrutide per week has no approved answer
A Phase 2 study tested 1, 4, 8, and 12 mg weekly [1]. At 12 mg, weight fell 24.2% by week 48.
Those amounts belong to a controlled study. They aren't a dose plan for you.
Retatrutide has no approved label. No lawful weekly amount exists for patients.
Mixing retatrutide with germ-slowing water isn't safe
Water made to slow germs is sometimes called bacteriostatic water. This site gives no mixing directions for online shots.
No approved retatrutide product has a mixing rule. Study staff used drug made for the trial.
They didn't ask people to mix it. An online vial may be false or dirty.
Adding special water can't make an unknown powder safe.
How to switch from tirzepatide to retatrutide has no study plan
You can't lawfully switch to an unapproved drug. No study has given doctors a switch plan.
A controlled study now compares both drugs [11]. It isn't testing a home switch from one to the other.
Retatrutide can't be prescribed or sold as medicine. Ask your own doctor about approved care.
Retatrutide isn't a hormone called GLP-3
No hormone in your body is named GLP-3. Websites made up that nickname for retatrutide.
One is GLP-1, a gut hormone that can ease hunger. GLP-1 is only one of three messages copied by the drug.
The 3 in the nickname only points to those three jobs. It doesn't name a real hormone.
Scientists call retatrutide a three-part hormone drug [3][6]. The GLP-3 nickname is still wrong, and it can mislead you.
Retatrutide can't be sold as approved medicine
Under FDA rules, retatrutide can't be sold or prescribed as medicine. Whether merely having a vial breaks a local law depends on where you live.
Online sellers don't have approval to market retatrutide as medicine. Some received FDA warning letters for breaking federal law.
Sports rules can change too. If you compete, check the current banned-drug list.
This isn't legal advice. Your local law may treat the vial another way.
Retatrutide studies used weekly shots
Published studies used weekly shots [1][2][4]. A half-life near 6 days supported that study timing.
The drug fell slowly in blood between shots. That doesn't make weekly use safe for you.
There are no approved use directions. Retatrutide remains investigational and cannot be prescribed in routine care.
How to store retatrutide has no checked home answer
No checked home storage rule exists. Phase 2 teams stored their own study drug under tight controls.
Online vials don't have sound proof of shelf life. Heat or cold may harm an unknown product.
No paper gives storage rules for those vials. You can't judge safety from the label alone.
Retatrutide isn't the same drug as Ozempic
No. Ozempic contains semaglutide, while retatrutide is a different drug.
Semaglutide copies GLP-1, a gut hormone that can ease hunger. Retatrutide copies GLP-1 plus GIP and glucagon.
GIP helps your pancreas send insulin after food. Glucagon can make your body burn stored fat.
The FDA allows semaglutide for some uses. Retatrutide has no FDA approval, which limits what your doctor can prescribe.
Retatrutide isn't proven better than semaglutide
No direct study had answered that by mid-2026. Separate Phase 2 results can't settle it.
Retatrutide reached 24.2% at 12 mg over 48 weeks. Semaglutide results came from other Phase 3 studies.
The current Phase 3 study compares retatrutide with tirzepatide. It doesn't compare retatrutide with semaglutide.
You need one fair study before calling either drug better.
Retatrutide is being studied for three illnesses
Studies have tested retatrutide for obesity and type 2 diabetes. They also tested fatty liver tied to poor health.
The drug isn't approved for any of those uses. You can't get it as a lawful medicine.
A 2025 review also covered heart and kidney studies [6]. Those studies hadn't proved a new use.
Retatrutide acts through the gut, pancreas, and other cells
Retatrutide acts like three hormones on your cells. Your gut releases GLP-1, which can ease hunger.
A lab study tested how cells reacted to the GLP-1 effect [3]. Those cells sat in dishes, not whole people.
Your gut also releases GIP. It tells your pancreas to send insulin when you eat.
Your pancreas releases glucagon between meals. It may push blood sugar higher and help use stored fat.
A lab result can't tell how your whole body will respond. Human studies must show benefit and harm.
Retatrutide cost has no real price yet
There is no approved price because retatrutide isn't sold as medicine. Eli Lilly hasn't named a list price.
People who study drug prices used other GLP-1 hunger drugs to guess $1,000–$1,500/month before discounts. Eli Lilly hasn't backed that guess.
The guess may be wrong if retatrutide reaches sale. Online vials carry many asking prices.
You can't tell whether those products contain retatrutide. A price can't prove to you what's in a vial or how it might affect your health.